Type of diabetes-Type 2 Page 2 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

The effect of drugs that protect nerves in the early stage of diabetic eye disease

Posted by on Dec 11, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to assess whether giving drugs that protect nerves (brimonidine and somatostatin) into the eye can prevent or stop nerve damage in the eye of patients with type 2 diabetes (T2D). The main finding of this study was these drugs protected patients with nerve damage in the eye from the disease worsening. Some...

Read More

How effective is self-management with empagliflozin in the treatment of type 2 diabetes?

Posted by on Dec 8, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to see how effective intermittent use of empagliflozin (Jardiance) controlled by the patients is in the treatment of poorly controlled type 2 diabetes (T2D). The main finding of the study was that intermittent use of empagliflozin controlled blood sugars as effectively as those who take it every day. Some background...

Read More

Insulin or enhanced oral anti-diabetic tablet therapy in uncontrolled type 2 diabetes?

Posted by on Dec 5, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the effects of starting insulin therapy versus enhancing oral tablet therapy after failure with three oral anti-diabetic (OAD) tablets in patients with type 2 diabetes (T2D). The main finding of the study was that adding insulin after failure with three OADs was effective, however, it increased...

Read More

Is long-acting and fast-acting insulin combination injection as safe and effective as taking each separately?

Posted by on Dec 1, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare the effectiveness and safety of insulin degludec/insulin aspart (IDegAsp) combination once daily (OD) versus insulin glargine (IGlar) U100 OD+insulin aspart (IAsp) OD in patients with type 2 diabetes (T2D). The main finding of this study was that IDegAsp achieved similar blood sugar control and...

Read More

Evaluating the safety and effectiveness of a new drug for type 2 diabetes: LY3298176

Posted by on Oct 26, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effectiveness and safety of a new drug, LY3298176 for patients with Type 2 diabetes (T2D). The main finding of the study is that LY3298176 improved blood sugar control and was safe to use in these patients. Some background Insulin is a hormone that controls blood sugar. Patients with type 2 diabetes...

Read More

Evaluating the effects of dapagliflozin on fatty liver and liver scarring in Type 2 diabetes

Posted by on Sep 16, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effects of dapagliflozin (Farxiga) on the build-up of fat and scar tissue in the liver of patients with Type 2 diabetes (T2D) and fatty liver disease. This study concluded that dapagliflozin may reduce fat buildup and scarring in the liver in these patients. Some background About 40 – 50% of patients with...

Read More

Can strict control of blood glucose levels increase the mortality risk?

Posted by on Jul 24, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether strict control of blood glucose levels (glycemic control) increases mortality (risk of death) in older adults with type 2 diabetes (T2D). It was determined that tight glycemic control increases the mortality risk in such persons when it is achieved with metformin (Glucophage), sulfonylureas, or insulin. Some...

Read More

Diabetes Burnout

Diabetes Burnout

Posted by on May 20, 2018 in Blog, Diabetes mellitus | 6 comments

“I just don’t think about my diabetes. It’s too complicated and I’m too busy.” “I’ve given up on carb counting and just eat whatever.” “If my blood sugar is out of range, I just don’t care.” “Family and friends don’t support me. ” “I feel hopeless.” If these...

Read More

Does intensive blood pressure control provide beneficial outcomes for patients with diabetes?

Posted by on Mar 31, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether a systolic blood pressure (SBP) of 120 mm Hg or less is beneficial for patients with diabetes, and determined their outcomes. This study concluded that this intensive blood pressure control improves cardiovascular outcomes in those with diabetes. Some background Proper management of blood pressure (BP) in...

Read More

Could a moderate intake of wine be beneficial for patients with well-controlled diabetes?

Posted by on Jan 26, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study determined whether or not a moderate intake of wine would be overall beneficial for patients with well-controlled type 2 diabetes. The authors concluded that initiating the drinking of wine, as part of a healthy diet, modestly decreases heart-disease risk. Some background Moderate consumption of alcohol (particularly wine)...

Read More

Dipeptidyl peptidase-4 inhibitors are not associated with increased cancer risk

Posted by on Nov 8, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study reviewed data on the association between dipeptidyl peptidase-4 (DPP4) inhibitors and cancer development in patients with type 2 diabetes. They found that patients receiving DPP4 inhibitors were not at a greater risk of developing cancer.  Some background Management of type 2 diabetes requires stringent blood...

Read More